文献速递中医内科中药与中成药合理使用

系统药理学策略解析枳术丸治疗功能性消化不良的协同机制

System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of Zhi-zhu Wan for Functional Dyspepsia.
PubMed 文献 · Front Pharmacol · 2018-08-06

本研究构建了包含药代动力学参数、药理学数据和成分贡献评分的系统药理学模型,以解析枳术丸治疗功能性消化不良的潜在机制。经ADME筛选获得61个具有良好药代动力学特征和生物活性的成分,其靶点涉及炎症、胃肠蠕动和精神障碍相关通路,发挥协同互补作用。成分贡献评分显示29个成分贡献了总评分的90.18%,提示疗效源于多成分整体作用而非少数成分。

要点

  • 枳术丸通过多成分、多靶点协同作用于炎症、胃肠蠕动和精神障碍相关通路治疗FD。
  • 29个成分贡献了总成分贡献评分的90.18%,支持整体协同而非少数成分主导。
  • 系统药理学模型可为其他中药复方机制研究提供参考方法。

核心结论

  • 枳术丸通过作用于炎症、胃肠蠕动和精神障碍相关靶点,在通路层面发挥协同互补效应治疗功能性消化不良。
  • 成分贡献评分表明29个成分贡献总评分的90.18%,有效治疗作用源于所有活性成分而非少数成分。

研究设计与样本

  • 研究构建了包含药代动力学参数、药理学数据和成分贡献评分的系统药理学模型。
  • 通过计算机ADME筛选获得61个具有良好药代动力学特征和生物活性的成分,并进行成分靶点预测、GO分析和通路富集分析。

主要发现

  • 61个成分经ADME筛选具有良好药代动力学特征和生物活性。
  • 成分靶点涉及炎症、胃肠蠕动和精神障碍相关通路。
  • 29个成分贡献了枳术丸治疗FD总成分贡献评分的90.18%。

关键数值与推荐

  • 29个成分贡献总成分贡献评分的90.18%。

临床怎么用

  • 提示枳术丸治疗FD的多成分协同机制,支持整体复方用药而非仅关注少数成分。
  • 系统药理学方法可为中药复方机制研究和临床合理用药提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Functional dyspepsia (FD) is a widely prevalent gastrointestinal disorder throughout the world, whereas the efficacy of current treatment in the Western countries is limited. As the symptom is equivalent to the traditional Chinese medicine (TCM) term "stuffiness and fullness," FD can be treated with Zhi-zhu Wan (ZZW) which is a kind of Chinese patent medicine. However, the "multi-component" and "multi-target" feature of Chinese patent medicine makes it challenge to elucidate the potential therapeutic mechanisms of ZZW on FD. Presently, a novel system pharmacology model including pharmacokinetic parameters, pharmacological data, and component contribution score (CS) is constructed to decipher the potential therapeutic mechanism of ZZW on FD. Finally, 61 components with favorable pharmacokinetic profiles and biological activities were obtained through ADME (absorption, distribution, metabolism, and excretion) screening in silico. The related targets of these components are identified by component targeting process followed by GO analysis and pathway enrichment analysis. And systematic analysis found that through acting on the target related to inflammation, gastrointestinal peristalsis, and mental disorder, ZZW plays a synergistic and complementary effect on FD at the pathway level. Furthermore, the component CS showed that 29 components contributed 90.18% of the total CS values of ZZW for the FD treatment, which suggested that the effective therapeutic effects of ZZW for FD are derived from all active components, not a few components. This study proposes the system pharmacology method and discovers the potent combination therapeutic mechanisms of ZZW for FD. This strategy will provide a reference method for other TCM mechanism research.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Wang C, Ren Q, Chen XT, et al. System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of Zhi-zhu Wan for Functional Dyspepsia. Front Pharmacol. 2018. PMID: 30127739. doi:10.3389/fphar.2018.00841

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。